Cellectar Biosciences, Inc. (CLRB)
1.78
-0.09
(-4.81%)
USD |
NASDAQ |
Oct 02, 16:00
1.82
+0.04
(+2.25%)
After-Hours: 20:00
Cellectar Biosciences EPS Diluted (Quarterly) : -0.5666 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5666 |
| March 31, 2026 | -1.333 |
| December 31, 2025 | -1.249 |
| September 30, 2025 | -1.405 |
| June 30, 2025 | -3.386 |
| March 31, 2025 | -0.1433 |
| December 31, 2024 | -1.534 |
| September 30, 2024 | -0.3728 |
| June 30, 2024 | -0.1809 |
| March 31, 2024 | -0.9078 |
| December 31, 2023 | -0.4058 |
| September 30, 2023 | -46.48 |
| June 30, 2023 | -27.12 |
| March 31, 2023 | -19.16 |
| December 31, 2022 | -40.00 |
| September 30, 2022 | -1.278 |
| June 30, 2022 | -12.17 |
| March 31, 2022 | -1.005 |
| December 31, 2021 | -0.9686 |
| September 30, 2021 | -0.972 |
| June 30, 2021 | -1.142 |
| March 31, 2021 | -1.321 |
| December 31, 2020 | -0.7955 |
| September 30, 2020 | -1.485 |
| June 30, 2020 | -2.619 |
| Date | Value |
|---|---|
| March 31, 2020 | -4.215 |
| December 31, 2019 | -3.601 |
| September 30, 2019 | -4.159 |
| June 30, 2019 | -4.578 |
| March 31, 2019 | -7.587 |
| December 31, 2018 | -8.088 |
| September 30, 2018 | -16.51 |
| June 30, 2018 | -16.90 |
| March 31, 2018 | -21.00 |
| December 31, 2017 | -34.00 |
| September 30, 2017 | -26.00 |
| June 30, 2017 | -696.00 |
| March 31, 2017 | -24.07 |
| December 31, 2016 | -24.93 |
| September 30, 2016 | -43.00 |
| June 30, 2016 | -49.00 |
| March 31, 2016 | 91.00 |
| December 31, 2015 | 110.81 |
| September 30, 2015 | -250.00 |
| June 30, 2015 | -300.00 |
| March 31, 2015 | -300.00 |
| December 31, 2014 | -340.01 |
| September 30, 2014 | 60.00 |
| June 30, 2014 | -730.00 |
| March 31, 2014 | -1000.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.931M |
| Total Expenses (Quarterly) | 6.931M |
| Enterprise Value | -17.77M |
| Earnings Yield | -255.9% |
| Normalized Earnings Yield | -263.42 |